Shineco, Inc. (SISI)
USD 2.12
(-4.07%)
USD 2.12
(-4.07%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -22.44 Million USD | -121.86% |
| 2023 | -10.11 Million USD | -33.86% |
| 2022 | -7.55 Million USD | 63.71% |
| 2021 | -20.82 Million USD | -181.59% |
| 2020 | -7.39 Million USD | -1029.0% |
| 2019 | 796.18 Thousand USD | -89.51% |
| 2018 | 7.58 Million USD | -10.41% |
| 2017 | 8.46 Million USD | 4.09% |
| 2016 | 8.13 Million USD | 11.77% |
| 2015 | 7.28 Million USD | -6.99% |
| 2014 | 7.82 Million USD | 34.34% |
| 2013 | 5.82 Million USD | 0.0% |
| 2006 | 81.42 Thousand USD | -83.56% |
| 2005 | 495.24 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | -3.34 Million USD | 22.62% |
| 2024 Q1 | -3.48 Million USD | 0.52% |
| 2024 Q2 | -4.32 Million USD | -24.03% |
| 2024 Q4 | -20.13 Million USD | -501.39% |
| 2023 Q1 | -2.02 Million USD | -121.69% |
| 2023 Q2 | -1.92 Million USD | 4.83% |
| 2023 Q4 | -3.5 Million USD | -31.44% |
| 2023 Q3 | -2.66 Million USD | -38.81% |
| 2023 FY | -13.36 Million USD | 45.75% |
| 2022 Q2 | -2.87 Million USD | 74.08% |
| 2022 FY | -24.63 Million USD | 21.59% |
| 2022 Q1 | -11.1 Million USD | 1.71% |
| 2022 Q4 | 9.31 Million USD | 422.01% |
| 2022 Q3 | -2.89 Million USD | -0.52% |
| 2021 Q2 | -5.64 Million USD | -383.27% |
| 2021 Q1 | -1.16 Million USD | 38.49% |
| 2021 Q3 | -2.72 Million USD | 51.8% |
| 2021 Q4 | -11.29 Million USD | -315.28% |
| 2021 FY | -31.41 Million USD | -382.54% |
| 2020 Q1 | -1.79 Million USD | -443.94% |
| 2020 Q2 | 112.48 Thousand USD | 106.27% |
| 2020 Q3 | -3.81 Million USD | -3494.02% |
| 2020 Q4 | -1.89 Million USD | 50.26% |
| 2020 FY | -6.51 Million USD | -917.71% |
| 2019 Q4 | 521.21 Thousand USD | 148.18% |
| 2019 Q3 | -1.08 Million USD | -249.43% |
| 2019 FY | 796.18 Thousand USD | -89.51% |
| 2019 Q1 | 632.82 Thousand USD | 134.82% |
| 2019 Q2 | 723.88 Thousand USD | 14.39% |
| 2018 Q4 | -1.81 Million USD | -139.93% |
| 2018 FY | 7.58 Million USD | -10.41% |
| 2018 Q3 | 4.55 Million USD | 26.52% |
| 2018 Q2 | 3.59 Million USD | 186.47% |
| 2018 Q1 | 1.25 Million USD | -46.58% |
| 2017 Q4 | 2.35 Million USD | 22.28% |
| 2017 Q1 | 1.34 Million USD | -3.52% |
| 2017 Q2 | 2.84 Million USD | 111.15% |
| 2017 Q3 | 1.92 Million USD | -32.49% |
| 2017 FY | 8.46 Million USD | 4.09% |
| 2016 Q3 | 1.74 Million USD | -51.22% |
| 2016 Q1 | 1.42 Million USD | 45.96% |
| 2016 Q4 | 1.39 Million USD | -19.82% |
| 2016 FY | 8.13 Million USD | 11.77% |
| 2016 Q2 | 3.57 Million USD | 151.29% |
| 2015 FY | 7.28 Million USD | -6.99% |
| 2015 Q4 | 974.33 Thousand USD | -47.14% |
| 2015 Q3 | 1.84 Million USD | -37.62% |
| 2015 Q2 | 2.95 Million USD | 95.92% |
| 2015 Q1 | 1.5 Million USD | -53.1% |
| 2014 Q4 | 3.21 Million USD | 244.73% |
| 2014 Q2 | 1.92 Million USD | 0.0% |
| 2014 Q3 | 932.82 Thousand USD | -51.47% |
| 2014 Q1 | 1.92 Million USD | -8.15% |
| 2014 FY | 7.82 Million USD | 34.34% |
| 2013 Q4 | 2.09 Million USD | 32.14% |
| 2013 FY | 5.82 Million USD | 0.0% |
| 2013 Q3 | 1.58 Million USD | 0.0% |
| 2007 Q3 | 80.22 Thousand USD | 0.0% |
| 2007 Q1 | 7237.00 USD | 0.0% |
| 2006 Q3 | 53.8 Thousand USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2006 FY | 81.42 Thousand USD | -83.56% |
| 2005 FY | 495.24 Thousand USD | 0.0% |
| 2005 Q3 | 109.91 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Theratechnologies Inc. | -23.95 Million USD | 6.295% |
| Harrow Health, Inc. | -24.41 Million USD | 8.037% |
| Dynavax Technologies Corporation | -6.38 Million USD | -251.37% |
| Biofrontera Inc. | -20.13 Million USD | -11.515% |
| Cronos Group Inc. | -73.96 Million USD | 69.648% |
| Sonoma Pharmaceuticals, Inc. | -4.83 Million USD | -364.302% |
| Ironwood Pharmaceuticals, Inc. | -1 Billion USD | 97.76% |
| Kala Pharmaceuticals, Inc. | -42.19 Million USD | 46.802% |
| RedHill Biopharma Ltd. | 23.91 Million USD | 193.866% |
| Cumberland Pharmaceuticals Inc. | -6.27 Million USD | -257.507% |
| Radius Health, Inc. | -25.79 Million USD | 12.958% |
| Universe Pharmaceuticals INC | -6.16 Million USD | -264.251% |
| DURECT Corporation | -27.62 Million USD | 18.734% |
| ProPhase Labs, Inc. | -16.78 Million USD | -33.768% |
| Safety Shot Inc | -15.08 Million USD | -48.836% |
| Phibro Animal Health Corporation | 2.41 Million USD | 1029.181% |
| China SXT Pharmaceuticals, Inc. | -3.09 Million USD | -624.505% |
| Alvotech | -551.73 Million USD | 95.931% |
| Assertio Holdings, Inc. | -331.94 Million USD | 93.237% |
| Supernus Pharmaceuticals, Inc. | 1.31 Million USD | 1805.852% |
| Rockwell Medical, Inc. | -8.43 Million USD | -166.015% |
| Sunshine Biopharma, Inc. | -4.5 Million USD | -398.198% |
| Procaps Group S.A. | 42.54 Million USD | 152.772% |
| Intra-Cellular Therapies, Inc. | -139.67 Million USD | 83.928% |
| SCYNEXIS, Inc. | 67.04 Million USD | 133.486% |
| Aytu BioPharma, Inc. | -15.84 Million USD | -41.688% |
| Viatris Inc. | 54.7 Million USD | 141.04% |
| OptiNose, Inc. | -35.48 Million USD | 36.733% |
| SIGA Technologies, Inc. | 68.06 Million USD | 132.98% |
| Tilray Brands, Inc. | -244.98 Million USD | 90.836% |
| PetIQ, Inc. | 2.13 Million USD | 1153.45% |
| Sunshine Biopharma, Inc. | -4.5 Million USD | -398.198% |
| Neurocrine Biosciences, Inc. | 249.7 Million USD | 108.99% |
| Guardion Health Sciences, Inc. | 158.03 Thousand USD | 14305.272% |
| Alimera Sciences, Inc. | -20.13 Million USD | -11.509% |
| Collegium Pharmaceutical, Inc. | 48.15 Million USD | 146.618% |
| Silver Spike Investment Corp. | 7.34 Million USD | 405.84% |
| Shuttle Pharmaceuticals Holdings, Inc. | -6.59 Million USD | -240.512% |
| Organogenesis Holdings Inc. | 4.94 Million USD | 553.974% |
| Journey Medical Corporation | -3.85 Million USD | -482.637% |
| Petros Pharmaceuticals, Inc. | -8.16 Million USD | -175.003% |
| Alpha Teknova, Inc. | -36.78 Million USD | 38.964% |
| Clever Leaves Holdings Inc. | -17.89 Million USD | -25.421% |
| Lifecore Biomedical, Inc. | 12.01 Million USD | 286.873% |
| PainReform Ltd. | -9.34 Million USD | -140.251% |
| Cosmos Health Inc. | -18.54 Million USD | -21.067% |
| Avadel Pharmaceuticals plc | -160.27 Million USD | 85.994% |
| TherapeuticsMD, Inc. | -10.27 Million USD | -118.418% |
| Embecta Corp. | 70.4 Million USD | 131.888% |
| Regencell Bioscience Holdings Limited | -4.3 Million USD | -421.847% |
| Talphera, Inc. | -18.39 Million USD | -22.025% |
| Pacira BioSciences, Inc. | 41.95 Million USD | 153.507% |
| Incannex Healthcare Limited | -18.45 Million USD | -21.616% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | -11.924% |
| Procaps Group, S.A. | 42.54 Million USD | 152.772% |
| ANI Pharmaceuticals, Inc. | 18.77 Million USD | 219.543% |
| Aquestive Therapeutics, Inc. | -7.87 Million USD | -185.248% |
| Lantheus Holdings, Inc. | 326.66 Million USD | 106.872% |
| Alvotech | -551.73 Million USD | 95.931% |
| Hempacco Co., Inc. | -13.12 Million USD | -71.026% |
| Eagle Pharmaceuticals, Inc. | 35.64 Million USD | 162.985% |
| Bright Green Corporation | -13.12 Million USD | -71.006% |
| Esperion Therapeutics, Inc. | -209.24 Million USD | 89.272% |
| Kamada Ltd. | 8.28 Million USD | 370.992% |
| Indivior PLC | 2 Million USD | 1222.451% |
| Evoke Pharma, Inc. | -7.79 Million USD | -188.092% |
| Flora Growth Corp. | -57.03 Million USD | 60.641% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | -11.924% |
| Evolus, Inc. | -61.68 Million USD | 63.607% |
| HUTCHMED (China) Limited | 100.78 Million USD | 122.275% |
| Amphastar Pharmaceuticals, Inc. | 137.54 Million USD | 116.321% |
| Akanda Corp. | -32.27 Million USD | 30.445% |